The Story
Summary
Adham wanted to be a doctor, studied genetics, and ended up running a small Nigerian hospital. Running it exposed a medicine supply problem, and DrugStoc followed. Interviews from December 2021 and March 2022 cover growth from 20 facilities to over 3,000, a $4.4M Series A and advice on persistence.
Details
In a March 2022 People of Color in Tech interview, Adham says the goal was to be a doctor until high school ended. The first degree was in genetics, and it served as pre-med. Adham's father owns a small hospital in Nigeria, and Adham was put in charge of it at 20. The job meant HR, managing doctors, accounting and standardizing operations. Adham calls it a first introduction to entrepreneurship.
Adham told Technext that running a hospital brought two problems into focus. One was a high staff attrition rate tied to Nigeria's brain drain. The other was that the accessibility and quality of products available to providers were next to none. Adham ties that second problem to the company started in 2017. Adham went to Holland for a master's degree, with a thesis on the Nigerian healthcare system. Adham was asked to find an associate professor to review the thesis, and that search led to Opara, who was doing a PhD at the time.
The People of Color in Tech profile says Adham previously co-founded Integra-Health, a health consultancy and IT lab based in Lagos. Technext describes DrugStoc as a procurement platform where hospitals and pharmacies source medications, consumables and small medical equipment, and says Opara and Adham founded it in 2017. Adham told Technext that DrugStoc was selected for the Stanford University Seed program, which helped the team redefine how it looked at medicine, supply chain and finance. In the other interview, Adham describes a six-month Stanford bootcamp that focused the team on its value proposition.
In the December 2021 Technext interview, Adham says the business grew from supplying 20 facilities to over 3,000 since inception, and that most clients arrive via referrals from existing clients. Adham also says DrugStoc deals with over 400 manufacturers. Technext reports that DrugStoc secured a $4.4M Series A in November 2021. Africa HealthCare Master Fund (AAIC) led the round, with Vested World and Germany's DEG taking part.
In the March 2022 interview, the interviewer says Adham had mentioned that the first beta product failed but needed to fail to reach the present point. Asked whether founders give up too easily, Adham says to be as stubborn as possible about the goal, and to be rigid about the passion to change a sector rather than about the idea itself. The piece's introduction says DrugStoc was a top 10 finalist in the 2019 Jack Ma Africa Netpreneur Prize Initiative.










